CARDURA

LOE Approaching

doxazosin

NDAORALTABLET
Approved
Nov 1990
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
7

Mechanism of Action

(BPH) The symptoms associated with benign prostatic hyperplasia (BPH), such as urinary frequency, nocturia, weak stream, hesitancy, and incomplete emptying are related to two components, anatomical (static) and functional (dynamic). The static component is related to an increase in prostate size…

Clinical Trials (5)

NCT03339258Phase 2Active Not Recruiting

A Randomized Controlled Trial of Doxazosin for Nightmares, Sleep Disturbance, and Non-Nightmare Clinical Symptoms in PTSD

Started Apr 2018
80 enrolled
Stress Disorders, Post-Traumatic
NCT01959022Phase 4Completed

A Pilot Study to Assess the Effects of Doxazosin on Polysomnography in PTSD

Started Oct 2013
15 enrolled
Stress Disorders, Post-Traumatic
NCT01389609Phase 1Completed

Bioequivalence Study of Doxazosin 4 Mg Orally-Disintegrating Tablet With Or Without Water To Doxazosin 4 Mg Japanese Marketed Immediate Release Tablet Under Fasted Condition

Started Jul 2011
24 enrolled
Hypertension
NCT01003886N/ACompleted

A Post Marketing Surveillance Study Of Doxazosin Mesylate GITS Among Filipino Patients With Benign Prostatic Hyperplasia (BPH)

Started May 2009
989 enrolled
Prostatic Hyperplasia
NCT00130156Phase 4Completed

Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension

Started Oct 2005
93 enrolled
High Blood Pressure